Neonc Technologies Holdings (NTHI) Total Current Liabilities (2024 - 2026)
Neonc Technologies Holdings (NTHI) posted quarterly Total Current Liabilities of $16.3 million for Q1 2026, down 9.84% year-over-year from $18.1 million in Q1 2025, and down 18.73% quarter-over-quarter from $20.0 million in Q4 2025.
Neonc Technologies Holdings (NTHI) Total Current Liabilities (2024 - 2026) Analysis & Trends
Neonc Technologies Holdings (NTHI) has reported Total Current Liabilities for 3 consecutive years, with $16.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities fell 9.84% year-over-year to $16.3 million; the TTM figure through Mar 2026 stood at $16.3 million (down 9.84% YoY), while the FY2025 annual figure was $20.0 million, up 124.62% from the prior year.
- Total Current Liabilities slipped to $16.3 million in Q1 2026 per NTHI's latest filing, from $20.0 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $20.0 million in Q4 2025 and bottomed at $8.9 million in Q4 2024.
- Historically, Total Current Liabilities has averaged $15.6 million across 3 years, with a median of $15.9 million in 2025.
- Annual changes were most pronounced in 2025 — Total Current Liabilities surged 124.62% — and 2026, when it decreased 9.84%.
- Neonc Technologies Holdings' Total Current Liabilities stood at $8.9 million in 2024, then soared by 124.62% to $20.0 million in 2025, then dropped by 18.73% to $16.3 million in 2026.
- Business Quant data shows NTHI's Total Current Liabilities at $16.3 million in Q1 2026, $20.0 million in Q4 2025, and $15.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 630.93 Mn |
| 10 | Neonc Technologies Holdings | 116.41 Mn | 116.41 Mn | - | 23.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.51 Mn |
| Mar 31, 2026 | 16.29 Mn |
| Dec 31, 2025 | 20.04 Mn |
| Sep 30, 2025 | 15.59 Mn |
| Jun 30, 2025 | 14.48 Mn |
| Mar 31, 2025 | 18.07 Mn |
| Dec 31, 2024 | 8.92 Mn |